These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 33147877)

  • 1. Epidemiology and Diagnosis of Mucormycosis: An Update.
    Skiada A; Pavleas I; Drogari-Apiranthitou M
    J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33147877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Mucormycosis in India.
    Prakash H; Chakrabarti A
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33806386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis in India: unique features.
    Chakrabarti A; Singh R
    Mycoses; 2014 Dec; 57 Suppl 3():85-90. PubMed ID: 25187095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Epidemiology of Mucormycosis.
    Prakash H; Chakrabarti A
    J Fungi (Basel); 2019 Mar; 5(1):. PubMed ID: 30901907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections - a study from a tertiary care hospital in north India
    Chander J; Singla N; Kaur M; Punia RS; Attri A; Alastruey-Izquierdo A; Cano-Lira JF; Stchigel AM; Guarro J
    Infect Dis (Lond); 2017 Mar; 49(3):170-177. PubMed ID: 27701965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India.
    Chander J; Kaur M; Singla N; Punia RPS; Singhal SK; Attri AK; Alastruey-Izquierdo A; Stchigel AM; Cano-Lira JF; Guarro J
    J Fungi (Basel); 2018 Apr; 4(2):. PubMed ID: 29642408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.
    Prabhu RM; Patel R
    Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():31-47. PubMed ID: 14748801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise of mucormycosis during the COVID-19 pandemic and the challenges faced.
    Kottarathil M; Thayanidhi P; P S; Jyoti Kindo A
    Curr Med Mycol; 2023 Mar; 9(1):44-55. PubMed ID: 37867589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal Taxa Responsible for Mucormycosis/"Black Fungus" among COVID-19 Patients in India.
    Divakar PK
    J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Epidemiology of Mucoralean Fungi: Chronic Cutaneous Infection Caused by Mucor irregularis.
    Chander J; Kaur M; Bhalla M; Punia RS; Singla N; Bhola K; Alastruey-Izquierdo A; Stchigel AM; Guarro J
    Mycopathologia; 2015 Oct; 180(3-4):181-6. PubMed ID: 26170185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging fungal infections: focus on
    Troiano G; Nante N
    J Prev Med Hyg; 2021 Jun; 62(2):E382-E385. PubMed ID: 34604577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chapter 7: zygomycosis.
    Severo CB; Guazzelli LS; Severo LC
    J Bras Pneumol; 2010; 36(1):134-41. PubMed ID: 20209316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene.
    Nagao K; Ota T; Tanikawa A; Takae Y; Mori T; Udagawa S; Nishikawa T
    J Dermatol Sci; 2005 Jul; 39(1):23-31. PubMed ID: 15978416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical manifestations of mucormycosis.
    Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples.
    Gholinejad-Ghadi N; Shokohi T; Seifi Z; Aghili SR; Roilides E; Nikkhah M; Pormosa R; Karami H; Larjani LV; Ghasemi M; Haghani I
    Mycoses; 2018 Dec; 61(12):909-915. PubMed ID: 30091261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging epidemiology of mould infections in developing countries.
    Chakrabarti A; Singh R
    Curr Opin Infect Dis; 2011 Dec; 24(6):521-6. PubMed ID: 21799406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
    Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.